HomeCompareVINCW vs PEP

VINCW vs PEP: Dividend Comparison 2026

VINCW yields 124.22% · PEP yields 3.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VINCW wins by $9.87M in total portfolio value
10 years
VINCW
VINCW
● Live price
124.22%
Share price
$1.61
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.01M
Annual income
$3,875,023.48
Full VINCW calculator →
PEP
PepsiCo Inc.
● Live price
3.66%
Share price
$155.29
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$144.7K
Annual income
$63,430.49
Full PEP calculator →

Portfolio growth — VINCW vs PEP

📍 VINCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVINCWPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VINCW + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VINCW pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VINCW
Annual income on $10K today (after 15% tax)
$10,559.01/yr
After 10yr DRIP, annual income (after tax)
$3,293,769.96/yr
PEP
Annual income on $10K today (after 15% tax)
$311.45/yr
After 10yr DRIP, annual income (after tax)
$53,915.92/yr
At 15% tax rate, VINCW beats the other by $3,239,854.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VINCW + PEP for your $10,000?

VINCW: 50%PEP: 50%
100% PEP50/50100% VINCW
Portfolio after 10yr
$5.08M
Annual income
$1,969,226.99/yr
Blended yield
38.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

VINCW
Analyst Ratings
1
Buy
Consensus: Buy
PEP
Analyst Ratings
1
Strong
15
Buy
28
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+11.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VINCW buys
0
PEP buys
0
No recent congressional trades found for VINCW or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVINCWPEP
Forward yield124.22%3.66%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$10.01M$144.7K
Annual income after 10y$3,875,023.48$63,430.49
Total dividends collected$9.13M$125.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: VINCW vs PEP ($10,000, DRIP)

YearVINCW PortfolioVINCW Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$23,122$12,422.36$10,854$514.44+$12.3KVINCW
2$51,585$26,844.33$11,982$758.21+$39.6KVINCW
3$111,167$55,970.88$13,526$1,136.44+$97.6KVINCW
4$231,676$112,727.29$15,727$1,741.93+$215.9KVINCW
5$467,452$219,558.47$19,012$2,750.28+$448.4KVINCW
6$914,194$414,020.78$24,173$4,514.44+$890.0KVINCW
7$1,734,916$756,728.27$32,789$7,793.80+$1.70MVINCW
8$3,198,495$1,342,134.90$48,258$14,354.51+$3.15MVINCW
9$5,734,878$2,312,488.60$78,586$28,686.63+$5.66MVINCW
10$10,011,343$3,875,023.48$144,688$63,430.49+$9.87MVINCW

VINCW vs PEP: Complete Analysis 2026

VINCWStock

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Full VINCW Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this VINCW vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VINCW vs SCHDVINCW vs JEPIVINCW vs OVINCW vs KOVINCW vs MAINVINCW vs MOVINCW vs PMVINCW vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.